Latest News about GSK
Recent news which mentions GSK
From Benzinga
From Motley Fool
From Benzinga
Moderna Investors Just Got Some Bullish News
June 03, 2024
From Motley Fool
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report
May 27, 2024
From Benzinga
From Benzinga
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
May 22, 2024
From Benzinga
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
May 21, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
From InvestorPlace
Is This a Setback for Moderna?
May 14, 2024
From Motley Fool
From Benzinga
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
May 10, 2024
From Benzinga
From Benzinga
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
May 08, 2024
From Benzinga
From InvestorPlace
Tickers
GSK
From InvestorPlace
From Benzinga
From Benzinga
Forget the Fed. These 3 Stocks Will Soar No Matter What
April 29, 2024
From InvestorPlace
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
From Benzinga
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
April 26, 2024
From Benzinga
What's Going On With Pfizer Stock On Thursday?
April 25, 2024
From Benzinga
From Benzinga
Once Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future
April 18, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.